| RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia F Matthijssens, ND Sharma, M Nysus, CK Nickl, H Kang, DR Perez, ... The Journal of clinical investigation 131 (6), 2021 | 29 | 2021 |
| Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia J Roels, M Thénoz, B Szarzyńska, M Landfors, S De Coninck, L Demoen, ... Blood cancer discovery 1 (3), 274-289, 2020 | 28 | 2020 |
| T-ALL can evolve to oncogene independence H Abdulla, A Vo, BJ Shields, TJ Davies, JT Jackson, R Alserihi, EM Viney, ... Leukemia 35 (8), 2205-2219, 2021 | 8 | 2021 |
| Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies T Pieters, S T’Sas, L Demoen, A Almeida, L Haenebalcke, F Matthijssens, ... Scientific Reports 9 (1), 10577, 2019 | 6 | 2019 |
| Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting E Pannecoucke, M Van Trimpont, J Desmet, T Pieters, L Reunes, ... Science Advances 7 (13), eabe1682, 2021 | 3 | 2021 |
| CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia BA Cardoso, M Duque, A Gírio, R Fragoso, ML Oliveira, JR Allen, ... Haematologica 109 (6), 1713, 2024 | 1 | 2024 |
| Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T‐cell lymphoblastic leukemia A Almeida, S T'Sas, L Pagliaro, I Fijalkowski, W Sleeckx, ... HemaSphere 8 (3), e51, 2024 | | 2024 |
| P326: A DUAL ROLE FOR PSIP1 IN T-ALL L Demoen, F Matthijssens, L Reunes, Z Debyser, S Goossens, ... HemaSphere 7 (S3), e96263b0, 2023 | | 2023 |
| P318: A DUAL ROLE FOR PSIP1 IN T-ALL L Demoen, F Matthijssens, Z Debyser, S Goossens, P Van Vlierberghe HemaSphere 6, 218-219, 2022 | | 2022 |
